DELIVERING
THE POWER
OF SCIENCE

Driving Innovation for
enhanced therapeutics and
consumer products
O2W_logo_final Sept 19 2022

Revolutionizing
Cannabinoid Delivery

The Next Generation Delivery System

O2W is the next generation of Lipid-Based Drug Delivery Systems (LBDDSs) that was engineered to significantly enhance the solubility, bioavailability, potency, stability and time of onset of fat-soluble compounds, including cannabinoids.

It is the art of transforming Oil-soluble compounds into Water-soluble compounds.

Free of Polyethylene Glycols (PEGs) and medium and short-chain alcohols, O2W is the only self-dispersing and fully water-dilutable Self-Microemulsifying Drug Delivery System (SMEDDS) made with food-grade excipients.

Unlike first generation PEG-based formulations, O2W does not compromise on:

Performance, Safety or Sustainability.

Breakthrough Product Platforms

Customizable and Tunable for every need

O2W Concentrate

Water-free Concentrate
Formulation Platform

High-potency, fast-acting
(immediate-release)

O2W Powder

Microencapsulated Powder
Formulation Platform

Extra high-potency,
tunable-release

O2W Gel

 

Semi-solid FormulationPlatform

High-potency, extended-release

 

Our breakthrough, proprietary product platforms can be customized to produce an unmatched variety of dosage forms with tunable release profiles.

Create the most unique and innovative products on the market, while providing your consumers with the best experience.

Unprecedented Performance

Fastest Oral bioavailability-enhancing formulation

According to Micellae’s pharmacokinetic (PK) study, O2W has an unprecedented onset of action, with the maximum concentration of CBD achieved at 20-30 min compared to unformulated CBD at 4-6 hours. This means your consumer will feel the effects in minutes, not hours.

O2W also demonstrated a substantial improvement of CBD bioavailability through a significant increase in area under curve (AUC) and Cmax, compared to control group.

O2W self-microemulsification under an electronic microscope.

Partner With Us

Take your product to the next generation

Our experts will work with you every step of the way to find the best solution for your product.

Integrating O2W into your manufacturing process and products is seamless and inexpensive.

Who Is Micellae

Micellae is an innovative technology-based company founded on 15 years of research and engineering at University of Toronto.

We aim to provide the most advanced Drug Delivery System to high-quality pharmaceutical, medical and recreational cannabis producers.

Our in-house scientific experts, led by CEO and founder, Dr. Mehdi Nouraei, are deeply knowledgeable about Drug Delivery Systems.

We’re further strengthened by an executive and advisory team with in-depth expertise and experience in the pharmaceutical and health care industries.

OUR PARTNERS

U of T Logo
logo-TIAP
logo-UTEST
logo-LSO
logo-reseach-canada

TO LEARN MORE

Visit our FAQS, MEDIA, Or CONTACT US

PEG is a broad name for a wide variety of products and is found...